Does ketamine cause extrapyramidal syndrome?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 15, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Does Ketamine Cause Extrapyramidal Syndrome?

No, ketamine does not cause extrapyramidal syndrome (EPS). Ketamine is not associated with dopamine receptor blockade or extrapyramidal side effects in the medical literature.

Mechanism and Evidence

Ketamine operates through a completely different mechanism than drugs that cause EPS. The available evidence discusses ketamine's effects on:

  • Hemodynamic parameters (sympathomimetic activity, blood pressure, heart rate) 1, 2
  • Respiratory effects (increased secretions, bronchodilation) 1
  • Dissociative symptoms (emergence reactions in 10-30% of adults, including hallucinations and delirium) 2
  • Psychotomimetic effects (occurring in approximately 20% of patients at 0.5 mg/kg) 3

None of the guideline literature identifies EPS as a side effect of ketamine.

Drugs That Actually Cause EPS

The evidence clearly identifies the medications that do cause extrapyramidal symptoms:

High-Risk Agents

  • High-potency antipsychotics (e.g., haloperidol) produce the most EPS through dopamine receptor blockade 1
  • Low-potency antipsychotics (e.g., thioridazine, chlorpromazine) cause less EPS but more anticholinergic effects 1

Other Causative Agents

  • Selective serotonin reuptake inhibitors (SSRIs), particularly escitalopram, can cause EPS through serotonergic input to dopaminergic pathways 4
  • Certain antidepressants, antiemetics, lithium, and rarely anticonvulsants can produce EPS indistinguishable from neuroleptic-induced symptoms 5, 6

Clinical Implications

If a patient on ketamine develops extrapyramidal symptoms, look for concomitant medications or other causes. The EPS is not from the ketamine itself. Common EPS presentations include:

  • Acute dystonia (sudden muscle spasms, oculogyric crisis) 1
  • Parkinsonism (bradykinesia, tremors, rigidity) 1
  • Akathisia (severe restlessness, pacing) 1, 4
  • Tardive dyskinesia (involuntary movements, typically orofacial) 1

Children and adolescents are at higher risk for EPS from antipsychotics than adults, but this is irrelevant for ketamine use 1.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Ketamine's Hemodynamic Effects

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Ketamine in Schizophrenia: Clinical Role and Evidence

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Extrapyramidal reactions following treatment with antidepressants: Results of the AMSP multinational drug surveillance programme.

The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry, 2020

Research

Nonneuroleptic etiologies of extrapyramidal symptoms.

Clinical nurse specialist CNS, 1993

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.